I agree that this site is using cookies. You can find further informations here.
X
Wainberg, Zev A
259  results:
Search for persons X
?
1

Bemarituzumab as first-line treatment for locally advanced ..:

Wainberg, Zev A. ; Kang, Yoon-Koo ; Lee, Keun-Wook...
Gastric Cancer.  27 (2024)  3 - p. 558-570 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Stud..:

Garralda, Elena ; Oh, Do Youn ; Italiano, Antoine...
The Journal of Clinical Pharmacology.  64 (2024)  5 - p. 544-554 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Clinical and pathological factors associated with survival ..:

Shimizu, Takayuki ; Maeda, Shimpei ; Link, Jason...
Surgery.  175 (2024)  5 - p. 1377-1385 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Monoclonal antibodies that target fibroblast growth factor ..:

Katoh, Masuko ; Nakayama, Izuma ; Wainberg, Zev A..
Clinical and Translational Medicine.  14 (2024)  6 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Mo1250 PATHOLOGICAL COMPLETE RESPONSE (PCR) TO DURVALUMAB P..:

Molena, Daniela ; Janjigian, Yelena ; Al-Batran, Salah-Eddin...
Gastroenterology.  166 (2024)  5 - p. S-996 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in p..:

Pant, Shubham ; Wainberg, Zev A. ; Weekes, Colin D....
Nature Medicine.  30 (2024)  2 - p. 531-542 , 2024
Link: https://doi.org/10.1038/..
 
?
7

Liposomal irinotecan, oxaliplatin, and S-1 as first-line th..:

Jeong, Hyehyun ; Kim, Bum Jun ; Lee, Choong-kun...
European Journal of Cancer.  208 (2024)  - p. 114194 , 2024
Link: https://doi.org/10.1016/..
 
?
8

FGFR-targeted therapeutics: clinical activity, mechanisms o..:

Katoh, Masuko ; Loriot, Yohann ; Brandi, Giovanni...
Nature Reviews Clinical Oncology.  21 (2024)  4 - p. 312-329 , 2024
Link: https://doi.org/10.1038/..
 
?
9

Results of a Randomized, Double-Blind, Placebo-Controlled, ..:

Gardner, Faithlore P. ; Wainberg, Zev A. ; Fountzilas, Christos...
Cancers.  16 (2024)  7 - p. 1323 , 2024
Link: https://doi.org/10.3390/..
 
?
10

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatmen..:

Wainberg, Zev A ; Melisi, Davide ; Macarulla, Teresa...
The Lancet.  402 (2023)  10409 - p. 1272-1281 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Dabrafenib plus trametinib in patients with relapsed/refrac..:

Kreitman, Robert J. ; Moreau, Philippe ; Ravandi, Farhad...
Blood.  141 (2023)  9 - p. 996-1006 , 2023
Link: https://doi.org/10.1182/..
 
?
12

Phase Ib/II Study of the Efficacy and Safety of Binimetinib..:

Van Cutsem, Eric ; Yaeger, Rona ; Delord, Jean-Pierre...
The Oncologist.  28 (2023)  12 - p. e1209-e1218 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Exploratory Analysis of Patients With Gastric/Gastroesophag..:

Ogata, Takatsugu ; Narita, Yukiya ; Wainberg, Zev A....
Journal of Gastric Cancer.  23 (2023)  2 - p. 289 , 2023
Link: https://doi.org/10.5230/..
 
?
14

Association between gene expression signatures and clinical..:

Shitara, Kohei ; Di Bartolomeo, Maria ; Mandala, Mario...
Journal for ImmunoTherapy of Cancer.  11 (2023)  6 - p. e006920 , 2023
Link: https://doi.org/10.1136/..
 
?
15

Pembrolizumab plus chemotherapy versus placebo plus chemoth..:

Rha, Sun Young ; Oh, Do-Youn ; Yañez, Patricio...
The Lancet Oncology.  24 (2023)  11 - p. 1181-1195 , 2023
Link: https://doi.org/10.1016/..
 
1-15